Last 12 months
Inside the activity.
2 purchase rows · 4 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 2 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 1 |
| Aug 2026 | 0 | 1 |
| Sep 2026 | 0 | 1 |
| Oct 2026 | 0 | 1 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| October 12, 2026 Filed Oct 14, 2026 20:15 UTC |
Saroglou GeorgiosDirector · President and COO
|
SaleCommon Shares | 5,000 | $53.20 | $266,000.00 |
DisclosureSEC source: 0001193125-26-421684 · ownership.xml · nonDerivative · entry 1 Saroglou Georgios · CIK 0002052945 · Director · President and COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 37,000 Read SEC document |
| September 18, 2026 Filed Sep 22, 2026 20:15 UTC |
Kosmatos Theoharrys EvgeniosCFO and CAO
|
SaleCommon Shares | 10,000 | $53.00 | $530,014.00 |
DisclosureSEC source: 0001193125-26-397932 · ownership.xml · nonDerivative · entry 1 Kosmatos Theoharrys Evgenios · CIK 0002120925 · CFO and CAO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,700 Read SEC document |
| August 13, 2026 Filed Aug 17, 2026 20:15 UTC |
Hatzimichalis ClioDirector
|
SaleCommon Shares | 5,000 | $41.07 | $205,331.00 |
DisclosureSEC source: 0001193125-26-354081 · ownership.xml · nonDerivative · entry 1 Hatzimichalis Clio · CIK 0002120224 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,000 Read SEC document |
| July 14, 2026 Filed Jul 16, 2026 20:15 UTC |
Tommasino Nicholas FrancisDirector
|
SaleCommon Shares | 2,490 | $40.07 | $99,761.85 |
DisclosureSEC source: 0001193125-26-306135 · ownership.xml · nonDerivative · entry 1 Tommasino Nicholas Francis · CIK 0002115992 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,874 Read SEC document |
| July 08, 2026 Filed Jul 10, 2026 20:15 UTC |
TSAKOS NIKOLAOSDirector · Chief Executive Officer
|
GiftCommon Shares | 500,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-300915 · ownership.xml · nonDerivative · entry 2 TSAKOS NIKOLAOS · CIK 0001229508 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Indirect · By spouse Disclosed balance after: 500,000 Read SEC document |
| July 08, 2026 Filed Jul 10, 2026 20:15 UTC |
TSAKOS NIKOLAOSDirector · Chief Executive Officer
|
GiftCommon Shares | 500,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-300915 · ownership.xml · nonDerivative · entry 1 TSAKOS NIKOLAOS · CIK 0001229508 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 81,600 F1 · balance_after: Tsakos Energy Management Limited ("TEM") effected a transfer to the Reporting Person of 500,000 shares, which such transfer was effected in accordance with Rule 16a-13 of the Securities Exchange Act of 1934, as amended. Read SEC document |
| April 29, 2026 Filed Apr 30, 2026 20:05 UTC |
TSAKOS NIKOLAOSDirector · Chief Executive Officer
|
PurchaseCommon Shares | 12,500 | $39.95 | $499,355.00 |
DisclosureSEC source: 0001193125-26-197170 · ownership.xml · nonDerivative · entry 2 TSAKOS NIKOLAOS · CIK 0001229508 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Indirect · By Intermed Champion S.A. of Panama Disclosed balance after: 918,500 F3 · price: The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $39.635 to $40.35. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range. F2 · ownership.nature: Shares held by Intermed Champion S.A. of Panama ("Intermed"). The Reporting Person has or shares voting and dispositive power with respect to the shares held by Intermed and may be deemed to beneficially own such securities by virtue of such relationship. The Reporting Person disclaims beneficial ownership of such securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), except to the extent of his pecuniary interest therein, if any. This report shall not be deemed an admission that the Reporting Person is the beneficial owner of such securities for purposes of Section 16 of the Exchange Act or for any other purpose. Read SEC document |
| April 28, 2026 Filed Apr 30, 2026 20:05 UTC |
TSAKOS NIKOLAOSDirector · Chief Executive Officer
|
PurchaseCommon Shares | 12,500 | $39.92 | $498,986.25 |
DisclosureSEC source: 0001193125-26-197170 · ownership.xml · nonDerivative · entry 1 TSAKOS NIKOLAOS · CIK 0001229508 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Indirect · By Intermed Champion S.A. of Panama Disclosed balance after: 906,000 F1 · price: The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $39.4398 to $40.34. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range. F2 · ownership.nature: Shares held by Intermed Champion S.A. of Panama ("Intermed"). The Reporting Person has or shares voting and dispositive power with respect to the shares held by Intermed and may be deemed to beneficially own such securities by virtue of such relationship. The Reporting Person disclaims beneficial ownership of such securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), except to the extent of his pecuniary interest therein, if any. This report shall not be deemed an admission that the Reporting Person is the beneficial owner of such securities for purposes of Section 16 of the Exchange Act or for any other purpose. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.